EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Switching of Rafoxanide: a New Approach To Fighting Drug-Resistant Bacteria and Fungi

Mahmoud M Bendary iD, Marwa I Abd El-Hamid iD, Amira I Abousaty, Arwa R Elmanakhly, Walaa A Alshareef, Rasha A Mosbah, Majid Alhomrani, Mohammed M Ghoneim, Amr Elkelish, Nada Hashim iD, Abdulhakeem S Alamri, Helal F Al-Harthi und 1 weitere

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.02679-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Mahmoud M Bendary und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Faculty of Pharmacy, Port Said University, Port Said, Egypt. Hauptthemen laut MEDLINE: Antifungal Agents, Mycoses. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The drug repurposing strategy is an alternative approach to reducing drug development timelines with low cost, especially during outbreaks of disease caused by drug-resistant pathogens. Rafoxanide can disrupt the abilities of bacterial and fungal cells to adapt to stress conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsMycosesAnimalsMiceHumansRafoxanideFluconazoleEscherichia coliAnti-Bacterial Agentsbeta-LactamasesMicrobial Sensitivity TestsKlebsiella pneumoniaeFungiCefotaxime

Stichwörter der Autor:innen

in silicomouse protectionrafoxaniderepurposingresistanceresistance gene downregulationtreatment failure

Substanzen

Antifungal AgentsRafoxanideFluconazoleAnti-Bacterial Agentsbeta-LactamasesCefotaxime

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Faculty of Pharmacy, Port Said University, Port Said, Egypt.
  • Department of Microbiology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
  • Department of Microbiology, Faculty of Science, Zagazig University, Zagazig, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, October 6 University, 6th of October, Egypt.
  • Infection Control Unit, Zagazig University Hospital, Zagazig, Egypt.

ORCID-Profile: Mahmoud M Bendary, Marwa I Abd El-Hamid, Nada Hashim

Zitieren

APA

Bendary, M. M., Abd El-Hamid, M. I., Abousaty, A. I., Elmanakhly, A. R., Alshareef, W. A., Mosbah, R. A., Alhomrani, M., Ghoneim, M. M., Elkelish, A., Hashim, N., Alamri, A. S., Al-Harthi, H. F., & Safwat, N. A. (2023). Therapeutic Switching of Rafoxanide: a New Approach To Fighting Drug-Resistant Bacteria and Fungi. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02679-22

Vancouver

Bendary MM, Abd El-Hamid MI, Abousaty AI, Elmanakhly AR, Alshareef WA, Mosbah RA, et al. Therapeutic Switching of Rafoxanide: a New Approach To Fighting Drug-Resistant Bacteria and Fungi. Microbiology Spectrum. 2023. doi:10.1128/spectrum.02679-22

BibTeX
@article{Bendary2023,
  author = {Bendary, Mahmoud M and Abd El-Hamid, Marwa I and Abousaty, Amira I and Elmanakhly, Arwa R and Alshareef, Walaa A and Mosbah, Rasha A and Alhomrani, Majid and Ghoneim, Mohammed M and Elkelish, Amr and Hashim, Nada and Alamri, Abdulhakeem S and Al-Harthi, Helal F and Safwat, Nesreen A},
  title = {Therapeutic Switching of Rafoxanide: a New Approach To Fighting Drug-Resistant Bacteria and Fungi},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.02679-22}
}
Kostenlos starten →